continued from part 1 - Controller General of Patents, Designs, and ...

(12) PATENT APPLICATION PUBLICATION (21) Application No.6578/DELNP/2008 A
(19) INDIA
(22) Date of filing of Application :29/07/2008 (43) Publication Date : 24/10/2008
(54) Title of the invention : "IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR
THE PREAPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME"
(51) International classification :C07D 487/04
(71)Name of Applicant :
1)CRYSTALGENOMICS, INC.
Address of Applicant :6F, 2ND BUILDING OF ASAN
INSTITUTE FOR LIFE SCIENCE, ASAN MEDICAL CENTER,
#388-1, PUNGNAP-2-DONG, SONGPA-GU, SEOUL 138-736,
(31) Priority Document No :10-2006-0006834 REPUBLIC OF KOREA. Republic of Korea
(32) Priority Date :23/01/2006
2)YUYU PHARMA.INC.
(33) Name of priority country :Republic of Korea (72)Name of Inventor :
(86) International Application No :PCT/KR2007/000393 1)LEE, SEUNG CHUL
Filing Date
:23/01/2007
2)CHOI,JIN SEOK
(87) International Publication No :WO 2007/083978 3)OH,JUNG HOON
(61) Patent of Addition to Application
Number
Filing Date
:NA
:NA
4)PARK,BOONSAENG
5)KIM, YONG EUN
6)LEE,JUN HEE
(62) Divisional to Application Number :NA
7)SHINE,DONGKYU
Filing Date
(57) Abstract :
:NA
8)KIM,CHEOL MIN
9)HYUN,YOUNG-LAN
10)LEE,CHEOL SOON
11)CHO, JOONG-MYUNG
12)RO, SEONGGU
The inventive imidazopyridine derivative can be used in a pharmaceutical composition for preventing or treating diseases such as
diabetes, obesity, dementia, cancer, and inflammation, since it can efficiently inhibit .the activities of several protein kinases including
glycogen synthase kinase-3 (GSK-3), aurora kinase, extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and the
likes, to control signal transductions thereof.
No. of Pages : 142 No. of Claims : 18
The Patent Office Journal 24/10/2008 26120